Find Your Protocol – NuroCore Labs

Mitochondrial Health: Where Longevity Research Got Serious

May 1, 2026

By a

A history of how mitochondria moved from textbook organelles to the centre of modern longevity research, what the evidence actually says about mitochondrial decline with age, and how the practical protocol picture has evolved since the Hallmarks of Aging paper.

Telomere Science: A Plain-English Guide to What It Actually Tells Us

April 30, 2026

By a

A patient explainer on telomeres, why the science is more complicated than the wellness industry suggests, and what the published research really supports for buyers thinking about telomere-related compounds.

Autophagy and Fasting: What the Published Research Actually Supports

April 29, 2026

By a

A measured review of the autophagy literature, what fasting actually does in human studies versus animal models, where the evidence is strong, and where the gap between published research and consumer claims is widest.

Protein Synthesis After 40: Anabolic Resistance and What Actually Works

April 28, 2026

By a

A practical, numbers-first picture of anabolic resistance, what protein doses actually work for adults over 40, the leucine threshold story, and how to think about supplementation alongside the lifestyle inputs that move the needle most.

Inflammaging: A Skeptical Look at What Chronic Inflammation Really Tells Us

April 27, 2026

By a

A journalistic look at the inflammaging concept, where the science is solid, where the supplement industry has run ahead of the data, and what a careful reader should and should not infer from a CRP test.

BPC-157 vs TB-500: What the Research Actually Distinguishes

April 25, 2026

By a

A skeptical comparison of the two most-asked-about recovery peptides. Where the literature actually separates them, where the buyer-side hype runs ahead of the data, and how the Wolverine pre-blend earns its place if you stack them.

GLP-Class Compounds: A Clinical Timeline of When Results Actually Show

April 22, 2026

By a

A clinical-tone timeline of what the published Phase 3 trials actually show across the GLP-class research compound family, week by week, and where the trial endpoints sit relative to when researchers ask the timeline question.

Peptide Stacking 101: How to Build a First Protocol Without Overcomplicating It

April 19, 2026

By a

A patient explainer for first-time researchers. What stacking actually means, why most beginner protocols overcomplicate the picture, and how to design a starter stack you can actually evaluate after eight weeks.

Apigenin: How a Chamomile Flavonoid Became a Sleep Compound Worth Taking Seriously

April 16, 2026

By a

A short history of apigenin, from its identification in chamomile in the 1840s to the modern research that put it back on the longevity-protocol radar, and what the molecular work actually supports for buyers thinking about sleep architecture.

NAD+ vs NMN: A Critical Look at What the Industry Sells vs What the Research Supports

April 13, 2026

By a

The longevity supplement industry has built itself around NAD+ precursors. The research behind those products is real but smaller in effect than the marketing implies. Here is the sharp version of the comparison, plus where the actual evidence sits.

Find your protocol in four questions.

Find Your Goal

Athlete Performance

Longevity Roadmap

Body Composition

Cognitive & Sleep

Skin & Aesthetic

Are you 21 or older?

Journal

Mitochondrial Health: Where Longevity Research Got Serious

Telomere Science: A Plain-English Guide to What It Actually Tells Us

Autophagy and Fasting: What the Published Research Actually Supports

Protein Synthesis After 40: Anabolic Resistance and What Actually Works

Inflammaging: A Skeptical Look at What Chronic Inflammation Really Tells Us

BPC-157 vs TB-500: What the Research Actually Distinguishes

GLP-Class Compounds: A Clinical Timeline of When Results Actually Show

Peptide Stacking 101: How to Build a First Protocol Without Overcomplicating It

Apigenin: How a Chamomile Flavonoid Became a Sleep Compound Worth Taking Seriously

NAD+ vs NMN: A Critical Look at What the Industry Sells vs What the Research Supports

Are you 21 or older?